Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
|Articles|November 2, 2015
- Pharmaceutical Technology-11-02-2015
- Volume 39
- Issue 11
Packaging Inspection Machines
Pharmaceutical inspection machines from Bosch Packaging Technology include the KHS 1, which uses laser headspace analysis (HSA), and the AIM 3, which uses high-voltage leak detection (HVLD), for container closure integrity testing.
Packaging Inspection Machines
Pharmaceutical inspection machines from Bosch Packaging Technology include the KHS 1, which uses laser headspace analysis (HSA), and the AIM 3, which uses high-voltage leak detection (HVLD), for container closure integrity testing.
The KHS 1 measures the absorbed light passing through the headspace region via laser spectroscopy. HSA is applicable to lyophilized products and medicines filled under vacuum or purged with inert gas. The machine inspects both standing and non-standing containers at outputs of up to 600 per minute and can combine HSA with optional near infrared (NIR) measurement and container coding. A built-in, automatic recalibration is continuously performed using certified reference containers to ensure reliability and accuracy.
The AIM 3 can perform both visual inspection and HVLD for ampoules and vials on one single platform. HVLD detects leaks by measuring the electrical resistance of containers with conductive solutions. The machine inspects ampoules and vials containing solutions and suspensions at outputs of up to 400 containers per minute. To sort out damaged containers before they enter the main inspection turret, the AIM 3 is equipped with a preinspection station. The core module uses a high-resolution camera with high-speed interface for particle and cosmetic inspection, as well as a reinspection function. The customizable platform can be retrofitted on-site to add further visual inspection stations or the HVLD module.
Bosch Packaging Technology
Articles in this issue
almost 11 years ago
Using Dynamic Thermal Imaging to Correct Sealing Problemsalmost 11 years ago
CMOs Continue to Improve Overall Biomanufacturing Performancealmost 11 years ago
FDA Overhauls Inspection Operationsalmost 11 years ago
Good Documentation Practice: Saving Data for the Long Termalmost 11 years ago
Identifying Causes Of Delaminationalmost 11 years ago
Piloting Track-and-Trace Implementationalmost 11 years ago
Advances in Heterocyclic Chemistry for API Synthesisalmost 11 years ago
EU’s New Telematics Strategy for the Regulation of Medicinesalmost 11 years ago
Exploring the Potential of Continuous Coatingalmost 11 years ago
Demonstrating Therapeutic Equivalence for Generic Topical ProductsRelated to this article
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Richard Jaenisch examines whether FDA's NAM pathway truly shortens drug pipelines or just shifts the evidentiary burden elsewhere.
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
PharmTech AI Pulse Check: Availability Bias Threatens AI Regulatory Reviews
4
Complying with International Pharmacopoeias
5